Patent details

Basic Information

Publication number:

EP3191094

PCT Application Number:

US2015048801

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157673831

PCT Publication Number:

WO2016040234

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF ANDROGEN DEPRIVATION THERAPY ASSOCIATED SYMPTOMS

French Title of Invention:

TRAITEMENT DES SYMPTÔMES ASSOCIÉS À UNE THÉRAPIE PAR DÉPRIVATION ANDROGÉNIQUE

German Title of Invention:

BEHANDLUNG VON MIT ANDROGENDEPRIVATIONSTHERAPIE ASSOZIIERTEN SYMPTOMEN

SPC Number:

Dates

Filing date:

08/09/2015

Grant date:

19/02/2020

EP Publication Date:

19/07/2017

PCT Publication Date:

17/03/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/02/2020

EP B1 Publication Date:

19/02/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/09/2020

Expiration date:

08/09/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/02/2020

 

 

Name:

Eli Lilly and Company

Address:

940 S. East Street, Indianapolis, IN 46206-6288, United States (US)

Inventor

Name:

BENSON, Charles Thomas

Address:

United States (US)

Priority

Priority Number:

201462049192 P

Priority Date:

11/09/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4439; A61P 5/26; A61P 19/08; A61P 21/00; A61P 21/06; C07D 209/94; C07D 401/06;

Publication

European Patent Bulletin

Issue number:

202008

Publication date:

19/02/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages